The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
- PMID: 10973253
- DOI: 10.1038/79216
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Abstract
Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associations have been reported for type 2 diabetes, but none have been confirmed in multiple samples and with comprehensive controls. We evaluated 16 published genetic associations to type 2 diabetes and related sub-phenotypes using a family-based design to control for population stratification, and replication samples to increase power. We were able to confirm only one association, that of the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(PPARgamma) with type 2 diabetes. By analysing over 3,000 individuals, we found a modest (1.25-fold) but significant (P=0.002) increase in diabetes risk associated with the more common proline allele (85% frequency). Moreover, our results resolve a controversy about common variation in PPARgamma. An initial study found a threefold effect, but four of five subsequent publications failed to confirm the association. All six studies are consistent with the odds ratio we describe. The data implicate inherited variation in PPARgamma in the pathogenesis of type 2 diabetes. Because the risk allele occurs at such high frequency, its modest effect translates into a large population attributable risk-influencing as much as 25% of type 2 diabetes in the general population.
Similar articles
-
[Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002. PMID: 12048686 Chinese.
-
[Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].Pol Arch Med Wewn. 2005 Nov;114(5):1055-65. Pol Arch Med Wewn. 2005. PMID: 16789503 Polish.
-
The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.Diabetes Res Clin Pract. 2003 Nov;62(2):105-11. doi: 10.1016/s0168-8227(03)00164-5. Diabetes Res Clin Pract. 2003. PMID: 14581147
-
The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):410-4. doi: 10.1097/MCO.0b013e3281e389d9. Curr Opin Clin Nutr Metab Care. 2007. PMID: 17563457 Review.
-
[The role of PPARgamma in the onset of type 2 diabetes].Nihon Yakurigaku Zasshi. 2003 Oct;122(4):317-24. doi: 10.1254/fpj.122.317. Nihon Yakurigaku Zasshi. 2003. PMID: 14501167 Review. Japanese.
Cited by
-
The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects.Diabetes Metab Syndr Obes. 2023 Nov 7;16:3557-3566. doi: 10.2147/DMSO.S429825. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37954888 Free PMC article. Review.
-
Pharmacogenetic studies update in type 2 diabetes mellitus.World J Diabetes. 2016 Aug 10;7(15):302-15. doi: 10.4239/wjd.v7.i15.302. World J Diabetes. 2016. PMID: 27555891 Free PMC article. Review.
-
Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside.PPAR Res. 2012;2012:978687. doi: 10.1155/2012/978687. Epub 2012 Jun 14. PPAR Res. 2012. PMID: 22745632 Free PMC article.
-
Validating therapeutic targets through human genetics.Nat Rev Drug Discov. 2013 Aug;12(8):581-94. doi: 10.1038/nrd4051. Epub 2013 Jul 19. Nat Rev Drug Discov. 2013. PMID: 23868113 Review.
-
PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.Curr Diab Rep. 2021 Apr 18;21(6):18. doi: 10.1007/s11892-021-01385-5. Curr Diab Rep. 2021. PMID: 33866450 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases